Advertisement

I-131-Lipiodol Therapy in Liver Neoplasms

  • J. H. Risse
  • F. Grünwald
  • H. Strunk
  • T. Bultmann
  • H. J. Biersack
Conference paper
Part of the Advances in Pharmacological Sciences book series (APS)

Abstract

11 patients with liver neoplasms (9 HCC,1 CCC,1multiple breast cancer metastases (BCM)) were treated by transarterial I-131-Lipiodol.CT and SPECT showed pronounced I-131-Lipiodol accumulation in the tumor tissue in all cases. In 2 HCC a significant reduction of tumor size was achieved. Of the patients with big tumor mass, 5 (4 HCC, 1 CCC) had stable disease, and 2 HCC were progressive. 1 patient died. The BCM proved significant reduction in number and size. 18-FDG-PET and CT controls showed in part different results with pretherapeutic PET proving high interindividual variability in tumor activity. Side effects were tolerabel.

Keywords

Portal Vein Thrombosis Breast Cancer Metastasis Primary Liver Cancer Percutaneous Ethanol Injection Sodium Perchlorate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    London W. Primary hepatocellular carcinoma — etiology,pathogenesis and prevention. Hum Pathol 1981; 12: 1085–1097.PubMedCrossRefGoogle Scholar
  2. 2.
    Maraj R, Kew MC, Hyslop RJ. Resectability rate of hepatocellular carcinoma in rural southern Africans. Br J Surg 1988; 75: 335–338.PubMedCrossRefGoogle Scholar
  3. 3.
    Groupe dé;etude et de traitement du carcinome hepatocellulaire. A comparison of Lipiodol chemoembolisation and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256–1261.CrossRefGoogle Scholar
  4. 4.
    Livraghi T, Bolondi L, Lazzaroni S et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992; 69: 925–929.PubMedCrossRefGoogle Scholar
  5. 5.
    Bretagne JF, Raoul XL, Bourguet P et al. Hepatic artery injection of I-131-labeled Lipiodol. Part 2: Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 547–550.PubMedGoogle Scholar
  6. 6.
    Raoul JL, Guyader D, Bretagne JF et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994; 35: 1782–1787.PubMedGoogle Scholar
  7. 7.
    Leung WT, Lau WY, Ho S et al. Selective internal radiation therapy with intra-arterial Iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 1994; 35: 1313–1318.PubMedGoogle Scholar
  8. 8.
    Novell R, Hilson A and Hobbs K. Ablation of recurrent primary liver cancer using 13-lipiodol. Postgrad Med J 1991; 67: 393–395.PubMedCrossRefGoogle Scholar
  9. 9.
    Schild HH, Kutzner J. Intraarterielle Applikation von Radionukliden. In: Interventionelle Radiologie. Günther RW, Thelen M, editors. Stuttgart New York: Thieme, 1996: 336–339.Google Scholar
  10. 10.
    Kobayashi H, Hidaka H, Kajiya Y et al. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol [Diagn] 1986; 27: 139–147.Google Scholar
  11. 11.
    Yoo HS, Lee JT, Kim KW et al. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine-131-labeled oil. Cancer 1991; 68: 1878–1884.PubMedCrossRefGoogle Scholar
  12. 12.
    Raoul JL, Bourguet P, Bretagne JF et al. Hepatic artery injection of I-131-labeled Lipiodol. Part 1: Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 541–545.PubMedGoogle Scholar

Copyright information

© Springer Basel AG 1999

Authors and Affiliations

  • J. H. Risse
    • 1
  • F. Grünwald
    • 1
  • H. Strunk
    • 1
  • T. Bultmann
    • 1
  • H. J. Biersack
    • 1
  1. 1.Nuclear Medicine Dep. and Radiology Dep.University of BonnBonnGermany

Personalised recommendations